Home   Contact   Partners

Roche NimbleGen


Chemistry custom R&D for biochip applications, novel chemistries for use in nucleic acid and protein arrays


NimbleGen Systems was acquired by Roche in 2007.


NimbleGen Systems Inc.
1 Science Court
Madison, WI 53711
Tel: (608) 218-7600
Fax: (608) 218-7601


The company’s Maskless Array Synthesis (MAS) technology uses digital light processing and rapid, high-yield photochemistry to synthesise long oligo, high-density DNA microarrays with extreme flexibility.

Related news